AU2494300A - 3,4-dihydro-2h-benzo(1,4)oxazine derivatives - Google Patents

3,4-dihydro-2h-benzo(1,4)oxazine derivatives

Info

Publication number
AU2494300A
AU2494300A AU24943/00A AU2494300A AU2494300A AU 2494300 A AU2494300 A AU 2494300A AU 24943/00 A AU24943/00 A AU 24943/00A AU 2494300 A AU2494300 A AU 2494300A AU 2494300 A AU2494300 A AU 2494300A
Authority
AU
Australia
Prior art keywords
benzo
dihydro
oxazine derivatives
oxazine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU24943/00A
Other languages
English (en)
Inventor
Richard Eric Mewshaw
Uresh Shantilal Shah
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
American Home Products Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Products Corp filed Critical American Home Products Corp
Publication of AU2494300A publication Critical patent/AU2494300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU24943/00A 1999-01-07 2000-01-06 3,4-dihydro-2h-benzo(1,4)oxazine derivatives Abandoned AU2494300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22683299A 1999-01-07 1999-01-07
US09226832 1999-01-07
PCT/US2000/000347 WO2000040581A1 (fr) 1999-01-07 2000-01-06 Derives de la 3,4-dihydro-2h benzo[1,4]oxazine

Publications (1)

Publication Number Publication Date
AU2494300A true AU2494300A (en) 2000-07-24

Family

ID=22850601

Family Applications (1)

Application Number Title Priority Date Filing Date
AU24943/00A Abandoned AU2494300A (en) 1999-01-07 2000-01-06 3,4-dihydro-2h-benzo(1,4)oxazine derivatives

Country Status (2)

Country Link
AU (1) AU2494300A (fr)
WO (1) WO2000040581A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028685A1 (es) * 2000-06-14 2003-05-21 Lundbeck & Co As H Derivados de indol
CA2426706A1 (fr) 2000-10-26 2002-05-02 Smithkline Beecham P.L.C. Derives de benzoxazinone, leur preparation et utilisation
CZ20032644A3 (en) 2001-03-29 2004-06-16 Bristol-Myers Squibb Company Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
WO2003006455A1 (fr) * 2001-07-11 2003-01-23 Eli Lilly And Company Composes pharmaceutiques a activite de recepteur de serotonine
GB0203804D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
WO2004106298A1 (fr) * 2003-05-30 2004-12-09 Janssen Pharmaceutica N.V. Derive d'indole a activite antipsychotique amelioree
ATE508129T1 (de) 2004-03-30 2011-05-15 Vertex Pharma Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole
DE602005016836D1 (de) 2004-11-26 2009-11-05 Janssen Pharmaceutica Nv Chotischer und anxiolytischer aktivität
EP2815750A1 (fr) 2006-12-21 2014-12-24 Vertex Pharmaceuticals Incorporated Dérivés de 5-cyano-4-(pyrrolo [2,3b] pyridine-3-yl)-pyrimidine utiles en tant qu'inhibiteurs de kinase de protéine
GEP20156325B (en) 2009-06-17 2015-07-10 Vertex Pharma Inhibitors of influenza viruses replication
MX2013006836A (es) 2010-12-16 2013-09-26 Vertex Pharma Inhibidores de la replicacion de los virus de la influenza.
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
RS59144B1 (sr) 2013-11-13 2019-09-30 Vertex Pharma Inhibitori replikacije virusa influence
EP3421468B1 (fr) 2013-11-13 2020-11-04 Vertex Pharmaceuticals Incorporated Procédés de préparation d'inhibiteurs de réplication de virus de la grippe
WO2016183116A1 (fr) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Procédés de préparation d'inhibiteurs de réplication des virus de la grippe
WO2016183120A1 (fr) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibiteurs de la réplication des virus de la grippe
JP6857651B2 (ja) 2015-11-06 2021-04-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Cns疾患の処置に有用なインドリン−2−オン誘導体
EP3371174B1 (fr) 2015-11-06 2021-03-17 H. Hoffnabb-La Roche Ag Dérivés d'indolin-2-one
JP6857662B2 (ja) 2015-11-06 2021-04-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft インドリン−2−オン誘導体
CN108349942B (zh) 2015-11-06 2021-03-30 豪夫迈·罗氏有限公司 用于治疗cns和相关疾病的二氢吲哚-2-酮衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8803419D0 (en) * 1988-02-15 1988-03-16 Erba Carlo Spa 1 4-benzoxazine & 1 4-benzothiazine derivatives & process for their preparation
AU3476599A (en) * 1998-04-08 1999-10-25 American Home Products Corporation Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression (5-ht1 receptor antagonists)

Also Published As

Publication number Publication date
WO2000040581A1 (fr) 2000-07-13

Similar Documents

Publication Publication Date Title
AU2494300A (en) 3,4-dihydro-2h-benzo(1,4)oxazine derivatives
AU2001230026A1 (en) 2,4-diaminothiazole derivatives
AU2002361992A1 (en) 1,4-dihydro-1,4-diphenylpyridine derivatives
AU4006800A (en) 1,2-dithiolane derivatives
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
AUPQ407699A0 (en) Aminoalcohol derivatives
ZA200109595B (en) 13-methyl-erythromycin derivatives.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
AU2616199A (en) Novel bicyclene-substituted oxazolidinones
AU2003247706A1 (en) 6, 11-4-carbon bridged erythromycin derivatives
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
AU3670000A (en) Novel thiazolobenzimidazole derivatives
AU5429000A (en) Novel bicyclonucleoside derivatives
AU5444499A (en) Benzoxazine derivatives
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
AU2002218400A1 (en) 3-substituted 2,7-naphthyridin-1-yl derivatives
AU6314100A (en) Novel thiazine or pyrazine derivatives
AU2001263083A1 (en) Biologically active 4h-benzo(1,4)oxazin-3-ones
AU7124400A (en) Radiation-curable, cyanoacrylate-containing compositions
MXPA01011285A (es) Derivados de tio-oxindol.
AU7846700A (en) Oxazoline or oxazine coating compositions
AU2964899A (en) 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
AU2641899A (en) Heterocycle-fused benzothiazine derivatives
AU6423298A (en) 4-arylmethylene-1,4-dihydro-2h-azine derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase